Literature DB >> 15184443

Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion.

Trudy Dobbs1, Susan Kennedy, Chou-Pong Pau, J Steven McDougal, Bharat S Parekh.   

Abstract

Recently, we developed an immunoglobulin G (IgG)-capture BED-enzyme immunoassay (BED-CEIA) to identify recent human immunodeficiency virus (HIV) type 1 (HIV-1) seroconversion for use in incidence estimates. We have established an algorithm for its use; developed quality control reagents to monitor the assay; and evaluated its performance for interrun, intrarun, and operator variability. Analysis of 144 individual plates, which involved multiple plate lots and several operators over more than a year, indicated that the coefficients of variation (CVs) were between 10 and 15% for raw optical density (OD) values in the dynamic range between 0.5 and 2.0 OD units; the CVs decreased to 5 to 10% when the OD was normalized (OD-n; OD-n = specimen OD/calibrator OD). The intrarun CVs were generally in the range of 5 to 10% for specimens with ODs <0.5 and less than 5% for specimens with ODs >0.5. The level of concordance between multiple plate lots (n = 6) and multiple operators (n = 7) was quite high (R(2) > 0.9). Comparison of the results of the initial and the confirmatory tests with specimens with OD-n values </=1.5 demonstrated a high degree of correlation (R(2) = 0.92); 566 (92%) of 615 of specimens tested in the two modes retained the same classification (recent or long-term infection). The values for those specimens with changed classifications (n = 49) were close to the cutoff (OD-n = 1.0), as expected. The twofold difference in the HIV IgG contents between the controls and the calibrator reagents was exploited to monitor individual plate runs by using a control plot, which was incorporated into the spreadsheet for data entry and run monitoring. This information provides baseline data for the successful transfer of BED-CEIA to other laboratories and the use of BED-CEIA for the detection of recent HIV seroconversion and the calculation of incidence estimates worldwide.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184443      PMCID: PMC427871          DOI: 10.1128/JCM.42.6.2623-2628.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence.

Authors:  Denise Kothe; Robert H Byers; Samuel P Caudill; Glen A Satten; Robert S Janssen; W Harry Hannon; Joanne V Mei
Journal:  J Acquir Immune Defic Syndr       Date:  2003-08-15       Impact factor: 3.731

2.  Test of HIV incidence shows continuing HIV transmission in homosexual/bisexual men in England and Wales.

Authors:  G Murphy; J V Parry; S B Gupta; C Graham; L F Jordan; A N Nicoll; O N Gill
Journal:  Commun Dis Public Health       Date:  2001-03

3.  Utility of an HIV-1 RNA assay in the diagnosis of acute retroviral syndrome.

Authors:  D More; K O'Brien; E Walter
Journal:  South Med J       Date:  2000-10       Impact factor: 0.954

4.  Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence.

Authors:  Bharat S Parekh; M Susan Kennedy; Trudy Dobbs; Chou-Pong Pau; Robert Byers; Timothy Green; Dale J Hu; Suphak Vanichseni; Nancy L Young; Kachit Choopanya; Timothy D Mastro; J Steven McDougal
Journal:  AIDS Res Hum Retroviruses       Date:  2002-03-01       Impact factor: 2.205

5.  Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence.

Authors:  T C Quinn; R Brookmeyer; R Kline; M Shepherd; R Paranjape; S Mehendale; D A Gadkari; R Bollinger
Journal:  AIDS       Date:  2000-12-01       Impact factor: 4.177

6.  Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection.

Authors:  B S Parekh; C P Pau; M S Kennedy; T L Dobbs; J S McDougal
Journal:  AIDS Res Hum Retroviruses       Date:  2001-01-20       Impact factor: 2.205

7.  Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand.

Authors:  B S Parekh; D J Hu; S Vanichseni; G A Satten; D Candal; N L Young; D Kitayaporn; L O Srisuwanvilai; S Rakhtam; R Janssen; K Choopanya; T D Mastro
Journal:  AIDS Res Hum Retroviruses       Date:  2001-03-20       Impact factor: 2.205

8.  Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection.

Authors:  Bhupat D Rawal; Azucena Degula; Ludmila Lebedeva; Robert S Janssen; Frederick M Hecht; Haynes W Sheppard; Michael P Busch
Journal:  J Acquir Immune Defic Syndr       Date:  2003-07-01       Impact factor: 3.731

9.  Evaluation of a sensitive/less sensitive testing algorithm using the bioMérieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand.

Authors:  Carrie L Young; Dale J Hu; Robert Byers; Suphak Vanichseni; Nancy L Young; Robert Nelson; Philip A Mock; Kachit Choopanya; Robert Janssen; Timothy D Mastro; Joanne V Mei
Journal:  AIDS Res Hum Retroviruses       Date:  2003-06       Impact factor: 2.205

10.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.

Authors:  R S Janssen; G A Satten; S L Stramer; B D Rawal; T R O'Brien; B J Weiblen; F M Hecht; N Jack; F R Cleghorn; J O Kahn; M A Chesney; M P Busch
Journal:  JAMA       Date:  1998-07-01       Impact factor: 56.272

View more
  72 in total

1.  Incidence of recent human immunodeficiency virus infection at two voluntary counseling testing centers in Pernambuco, Brazil, from 2006 to 2009.

Authors:  Kledoaldo Oliveira de Lima; Daniela Medeiros Salustiano; Maria Rosângela Cunha Duarte Coêlho; Ana Maria Salustiano Cavalcanti; Ricardo Sobhie Diaz; Heloísa Ramos Lacerda
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

2.  Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay.

Authors:  Oliver Laeyendecker; Ron Brookmeyer; Amy E Oliver; Caroline E Mullis; Kevin P Eaton; Amy C Mueller; Lisa P Jacobson; Joseph B Margolick; Joelle Brown; Charles R Rinaldo; Thomas C Quinn; Susan H Eshleman
Journal:  AIDS Res Hum Retroviruses       Date:  2011-12-01       Impact factor: 2.205

3.  Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries.

Authors:  Oliver Laeyendecker; Ron Brookmeyer; Caroline E Mullis; Deborah Donnell; Jairam Lingappa; Connie Celum; Jared M Baeten; Mary S Campbell; Max Essex; Guy de Bruyn; Carey Farquhar; Thomas C Quinn; Susan H Eshleman
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10       Impact factor: 2.205

4.  Seroincidence of recent human immunodeficiency virus type 1 infections in China.

Authors:  Yao Xiao; Yan Jiang; Jigang Feng; Wenyan Xu; Minjie Wang; Ellen Funkhouser; Sten H Vermund; Yujiang Jia
Journal:  Clin Vaccine Immunol       Date:  2007-08-01

5.  Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.

Authors:  Andrew F Longosz; David Serwadda; Fred Nalugoda; Godfrey Kigozi; Veronica Franco; Ronald H Gray; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-25       Impact factor: 2.205

6.  HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm.

Authors:  Matthew M Cousins; Jacob Konikoff; Oliver Laeyendecker; Connie Celum; Susan P Buchbinder; George R Seage; Gregory D Kirk; Richard D Moore; Shruti H Mehta; Joseph B Margolick; Joelle Brown; Kenneth H Mayer; Beryl A Koblin; Darrell Wheeler; Jessica E Justman; Sally L Hodder; Thomas C Quinn; Ron Brookmeyer; Susan H Eshleman
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

7.  Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.

Authors:  Neha S Shah; Yen T Duong; Linh-Vi Le; Nguyen Anh Tuan; Bharat S Parekh; Hoang Thi Thanh Ha; Quang Duy Pham; Cao Thi Thu Cuc; Trudy Dobbs; Tran Hong Tram; Truong Thi Xuan Lien; Nick Wagar; Chunfu Yang; Amy Martin; Mitchell Wolfe; Nguyen Tran Hien; Andrea A Kim
Journal:  AIDS Res Hum Retroviruses       Date:  2017-03-13       Impact factor: 2.205

8.  Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay.

Authors:  Andrew F Longosz; Charles S Morrison; Pai-Lien Chen; Eric Arts; Immaculate Nankya; Robert A Salata; Veronica Franco; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

Review 9.  Diagnosis of Human Immunodeficiency Virus Infection.

Authors:  Bharat S Parekh; Chin-Yih Ou; Peter N Fonjungo; Mireille B Kalou; Erin Rottinghaus; Adrian Puren; Heather Alexander; Mackenzie Hurlston Cox; John N Nkengasong
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

Review 10.  The potential role of biomarkers in HIV preventive vaccine trials.

Authors:  Ellen Maclachlan; Kenneth H Mayer; Ruanne Barnabas; Jorge Sanchez; Beryl Koblin; Ann Duerr
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-15       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.